Log in

Madrigal Pharmaceuticals SEC Filings & 10K Form (NASDAQ:MDGL)

$92.96
+0.83 (+0.90 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$90.97
Now: $92.96
$94.00
50-Day Range
$76.98
MA: $86.35
$93.49
52-Week Range
$74.05
Now: $92.96
$148.18
Volume105,528 shs
Average Volume124,473 shs
Market Capitalization$1.43 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.01

SEC Filings

Madrigal Pharmaceuticals (NASDAQ:MDGL) SEC Filings

DateFilerForm TypeView
02/11/2020
3:44 PM
Madrigal Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
01/28/2020
8:46 AM
Madrigal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
12/13/2019
4:14 PM
BAY CITY CAPITAL LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
12/13/2019
1:18 PM
BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP (Reporting)
Bay City Capital Fund IV, L.P. (Reporting)
BAY CITY CAPITAL LLC (Reporting)
Bay City Capital Management IV LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
1:08 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
12:41 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4/A
12/12/2019
4:31 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2019
4:27 PM
Madrigal Pharmaceuticals (Filer)
Form 424B7
12/10/2019
3:37 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:31 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2019
2:46 PM
Madrigal Pharmaceuticals (Subject)
Taub Rebecca (Filed by)
Form SC 13D/A
10/17/2019
2:46 PM
FRIEDMAN PAUL A (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
10/17/2019
2:45 PM
BAY CITY CAPITAL LLC (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13D/A
08/07/2019
8:10 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/11/2019
10:28 AM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2019
9:44 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2019
11:40 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
4:59 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:58 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:55 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:52 PM
Daly James M (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2019
4:47 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:39 PM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
4:13 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
12:50 PM
Madrigal Pharmaceuticals (Filer)
Form DEFA14A
05/15/2019
12:46 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
05/08/2019
5:20 PM
Lynch Brian Joseph (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/08/2019
7:51 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
3:27 PM
Madrigal Pharmaceuticals (Filer)
Form 10-K/A
03/12/2019
10:52 AM
Madrigal Pharmaceuticals (Filer)
Form CT ORDER
03/11/2019
2:42 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
2:42 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
2:41 PM
Madrigal Pharmaceuticals (Issuer)
Schneebaum Marc R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
7:51 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2019
3:29 PM
BAKER BROS. ADVISORS LP (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G
02/07/2019
3:00 PM
HealthCor Management, L.P. (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G
11/23/2018
7:53 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:26 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
5:09 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2018
5:43 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
7:50 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/19/2018
3:25 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
12:37 PM
Capital Research Global Investors (Filed by)
Madrigal Pharmaceuticals (Subject)
Form SC 13G
08/07/2018
7:51 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
5:08 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2018
3:19 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2018
7:52 PM
BATE KENNETH (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
6:03 PM
Levy Richard S (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
6:00 PM
Madrigal Pharmaceuticals (Issuer)
MILLIGAN DAVID V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
6:00 PM
Gollust Keith R (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
6:00 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
2:53 PM
Madrigal Pharmaceuticals (Issuer)
Schneebaum Marc R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
8:02 PM
CRAVES FRED B (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
7:56 PM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
7:55 PM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2018
7:50 PM
BAY CITY CAPITAL LLC (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
3:43 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
3:35 PM
Madrigal Pharmaceuticals (Filer)
Form 424B5
06/05/2018
3:01 PM
Madrigal Pharmaceuticals (Filer)
Form S-3ASR
05/31/2018
6:00 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
7:50 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
5:03 AM
Madrigal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/27/2018
4:05 PM
Madrigal Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/27/2018
3:10 PM
Madrigal Pharmaceuticals (Filer)
Form DEFA14A
04/27/2018
3:10 PM
Madrigal Pharmaceuticals (Filer)
Form DEF 14A
03/13/2018
7:51 AM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2018
5:02 AM
Madrigal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2018
11:47 AM
Madrigal Pharmaceuticals (Issuer)
Schneebaum Marc R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
11:47 AM
Madrigal Pharmaceuticals (Issuer)
Taub Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2018
11:46 AM
FRIEDMAN PAUL A (Reporting)
Madrigal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2017
3:47 PM
Madrigal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2017
7:47 PM
Madrigal Pharmaceuticals (Filer)
Form 424B5
12/18/2017
6:09 AM
Madrigal Pharmaceuticals (Filer)
Form 424B5
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel